Haem: Lymphoma 2, CLL and Lymphoproliferative disorder Pt.2 Flashcards

1
Q

Describe the typical presenting features of enteropathy-associated T cell lymphoma.

A
  • Abdominal pain/ obstruction/ bleeding/ perforation
  • Systemic symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why is it important to prevent EATL by following a strict gluten-free diet?

A

EATL responds poorly to chemotherapy and is usually fatal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common leukaemia in the Western world and what is its median age of presentation

A

Chronic lymphocytic leukaemia - proliferation of mature B-cells

Median age of presentation is 72

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the typical laboratory findings in a patient with CLL?

A
  1. Lymphocytosis
  2. Smear cells
  3. Normocytic normochromic anaemia
  4. Thrombocytopaenia
  5. Bone marrow lymphocytic replacement of normal marrow elements

NOTE: it is indolent so is often only picked up on routine blood tests

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What distinctive antigen phenotype (presence and absence) is suggestive of:

  • Mature B cells
  • Mature T cells
A
  1. Mature B cells:
    • CD19 positive
    • CD5 negative
  2. Mature T cells:
    • CD19 negative
    • CD5 positive
    • CD3 positive
    • CD4 or CD8 positive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Which antigen phenotype is suggestive of CLL?

A

CD19+ and CD5+

NOTE: this could potentially also be mantle cell lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which staging system is used for CLL?

A

Rai and Binet

Binet: stages A-C depending on number of lymphoid areas (< or > 3, Hb and platelets)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Which specific tests are used in CLL to help gauge prognosis?

A

FISH cytogenetic panel

  • TP53 mutation status

IgH V gene mutation status

CD38 expression (associated with poor prognosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do TP53 and IgH V gene mutations affect prognosis

A

TP53 - mutation/deletion associated with worse prognosis

IgH V gene - mutation associated with better prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between the VH genes of pre- and post-germinal centre B cells?

A

Pre-germinal centre: variable region is unmutated and looks identical to germline

Post-germinal centre: undergone somatic hypermutation so variable region is mutated and looks different to germline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the immunoglobulin levels you would expect to see in CLL.

A

Hypogammaglobulinaemia - because the malignant B cells are suppressing antibody production by other B cells

Leads to increased risk of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the term used to describe CLL changing into a high grade lymphoma?

A

Richter transformation - 1% risk per year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are some supportive measures used in the treatment of CLL?

A
  • Vaccination (covid, flu, pneumococcus)
  • Infection prophylaxis and treatment (e.g. PCP prophylaxis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How would autoimmune cytopaenias caused by CLL be treated?

A

Steroids

NOTE: 2nd line is rituximab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How would a Richter transformation be treated?

A

R-CHOP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is leukaemia-directed therapy?

A
  • Tailored to the patient
  • Usually involves watching and waiting because it is incurable by chemotherapy
  • Aim to establish remission

NOTE: young people may be cured with allogeneic stem cell transplantation

17
Q

What are some indications to stop watch and wait and initate treatment of CLL?

A
  • Progressive lymphocytosis (doubling in <6 months or >50% increase in 2 months)
  • Progressive bone marrow failure
  • Massive or progressive lymphadenopathy/splenomegaly
  • Systemic symptoms (B symptoms)
  • Autoimmune cytopaenias
18
Q

What is the first line treatment for TP53 intact CLL?

A

FCR - Fludarabine, Cyclophosphamide, Rituximab

NOTE: less intensive options may include, rituximab and bendamustine or obinutuzumab (anti-CD20) and chlorambucil (alkylating agent)

19
Q

What are some newer treatment options for high risk CLL?

A

B cell receptor kinase inhibitors

  • Bruton tyrosine kinase inhibitors - ibrutinib = (p53 mutation)
  • PI3K inhibitor - idelalisib

Bcl2 Inhibitors - venetoclax (effective but risk of tumour lysis syndrome)

CAR-T therapy

20
Q

Describe how CAR-T therapy for CLL works.

A
  • CAR-T are autologous T cells that are modified to contain chimeric antigen receptors
  • The internal part of the receptor is responsible for cell signalling
  • The external part is designed to target CD19 (on B cells) thereby enabling B cell depletion